Discoid lupus erythematosus
- Autores: Yusupova L.A.1, Garayeva Z.S.1, Yunusova E.I1, Mavlyutova G.I1, Fatkhutdinova L.I1
-
Afiliações:
- Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional Education
- Edição: Volume 29, Nº 14 (2022)
- Páginas: 10-14
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321152
- DOI: https://doi.org/10.18565/pharmateca.2022.14.10-14
- ID: 321152
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article presents data on discoid lupus erythematosus (DLE), characterized by a staged development of erythematous rash, follicular hyperkeratosis and cicatricial atrophy. Disease manifestations are associated with significant discomfort due to frequent occurrence on the face, scalp, ears; appearance of scarring. Factors that increase the likelihood of developing DLE include skin phototype I, drug intolerance, prolonged sun exposure, exposure to cold and wind, a history of chronic infection, and female gender. Ultraviolet radiation, dysregulation of the function of cytotoxic T-lymphocytes, dendritic cells and natural killers are pathogenetic components of the disease. Currently, the treatment of patients is associated with certain difficulties and the likelihood of relapse after discontinuation of drugs or after repeated exposure to trigger factors, which significantly worsens their quality of life.
Palavras-chave
Texto integral
Sobre autores
Luiza Yusupova
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional Education
Email: yuluizadoc@hotmail.com
Dr. Sci. (Med.), Professor, Head of the Department of Dermatovenereology and Cosmetology Kazan, Russia
Z. Garayeva
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional EducationKazan, Russia
E. Yunusova
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional EducationKazan, Russia
G. Mavlyutova
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional EducationKazan, Russia
L. Fatkhutdinova
Kazan State Medical Academy - Branch Campus of the Russian Medical Academy of Continuous Professional EducationKazan, Russia
Bibliografia
- Трофимов П.Н., Антонова О.В., Швырев Д.Н. и др. Кожные формы красной волчанки: патогенез, клиника, диагностика, терапия. Вестник дерматологии и венерологии. 2015;5:26.
- Farley-Loftus R., Elmariah S.B., Ralston J., et al. Hypertrophic discoid lupus erythematosus. Dermatol Online J. 2010;16(11):1.
- Юсупова Л.А. Современный взгляд на проблему старения кожи. Лечащий врач. 2017;6:75.
- Turan E., Sinem Bagci I., Turgut Erdemir A., et al. Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature. Acta Dermatovenerol Croat. 2014;22(2):150-59.
- Sole C., Domingo S., Ferrer B, Moline T., et al. MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus. J Invest Dermatol. 2019;139(1):51-61.
- Ерыгина Е.Н., Романова Н.В., Романов В.А. Метаболизм моноцитов и его связь с про-воспалительными цитокинами при дискоидной и системной красной волчанке. Медицинская иммунология. 2017;19:112.
- McDaniel B., Sukumaran S., Tanner L.S. Discoid Lupus Erythematosus. In: Stat Pearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021. PMID: 29630197.
- Сербина И.М. Комплексный подход к диагностике гнездной алопеции. Дерматовенерология. Косметология. Сексопатология. 2011;5:219.
- Motel PJ., Bernstein E.F., Fazio M., et al. Systemic lupus erythematosus in patients diagnosed with treatment-resistant acne.Int J Dermatol. 1995;34:338-40.
- Wang R.F., Maher M., Chung C., et al. Koebner phenomenon of discoid lupus erythematosus on old tattoos. Lupus. 2019;28(2):241-43. doi: 10.1177/0961203318815578.
- Salah E. Clinical and dermoscopic spectrum of discoid lupus erythematosus: novel observations from lips and oral mucosa.Int J Dermatol. 2018;57(7):830-36. doi: 10.1111/ijd.14015.
- Козин В.М., Козина Ю.В. Диагностика рубцующегося эритематоза. Вестник ВГМУ. 2018;5:137-41.
- Jessop S., Whitelaw D.A., Grainge M.J., et al. Drugs for discoid lupus erythematosus. Cochrane Database Syst. Rev. 2017;5(5):CD002954. doi: 10.1002/14651858.
- Wahie S., Daly A.K., Cordell H.J., et al. Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study. J. Invest. Dermatol. 2011;131(10):1981-86. doi: 10.1038/jid.2011.167.
- Ashraf E., Ghouse A.N., Siddiqui S., et al. Discoid Lupus Erythematosus: A Cross-Sectional Study From the Sindh Institute of Skin Diseases, Karachi, Pakistan. Cureus. 2020;12(10):e11201. doi: 10.7759/cureus.11201.
Arquivos suplementares
